On 7 July 2021, the International Coalition of Medicines Regulatory Authorities (ICMRA) is hosting a (virtual) workshop titled ‘Enabling Manufacturing Capacity in the COVID-19 Pandemic’ [link] with representatives from the leading association bodies representing biotech firms, developing and industrialized countries vaccine manufacturers, as well as innovative biopharmaceutical, generic and biosimilar companies. This first workshop with...
Read moreBoosting production of COVID-19 vaccines is key to ensuring there are enough doses for all populations most at risk. But manufacturing COVID-19 vaccines at the volumes the world needs is a colossal challenge and scarcity of raw materials and trade barriers could upset estimates that 11 billion doses – enough for the world’s adult population...
Read moreThese Data Ethics Principles are intended to help the pharmaceutical industry use data responsibly and sustainably, in alignment with the IFPMA Ethos of care, fairness, respect, and honesty. Ethical data use is critical to innovation, advancing scientific and medical understanding, ensuring patient safety, and improving healthcare for the benefit of individual patients and broader society....
Read more
This blog was originally published on the Media Planet Campaign Value of Vaccines on 25 June 2021. Over the past few decades, the global regulatory environment has become more stringent and demanding to consistently guarantee the quality, safety and efficacy of medicines and vaccines. The increase in requirements by regulatory authorities has not been implemented...
Read moreStep 1 of the biopharmaceuticals 5-step plan to address vaccine equity A number of countries with access to sufficient doses to vaccinate their own populations have pledged 1 billion doses so far for low- and middle-income (LMIC) countries in 2021 and 2022. We now need to ensure those pledges are realized and vaccines reach those...
Read moreIn light of the recent G7 Summit 2021, where the COVID-19 pandemic was understandably the overarching point of discussions, I was reminded about the key role our industry is playing in this health and economic crisis. This pandemic, the like of which has not been seen in over 100 years, has cost too many lives...
Read moreThe AMR Preparedness Index is the first-of-its-kind evaluation of how the governments of the 11 largest global economies are living up to their commitments to address antimicrobial resistance (AMR).
Read more
22 June – Paris/Geneva/London – Ministers of Health from four African countries (Algeria, Democratic Republic of Congo, Egypt and Cabo Verde), representatives from international organizations, patient groups and the pharmaceutical industry reiterated today at a high-level roundtable event the urgency of establishing a regulatory authority across Africa, especially in the context of the COVID-19 pandemic....
Read more